(Q38167953)

30 August 2017

Cardiovascular diseases and HCV infection: a simple association or more? (English)

1 reference

30 August 2017

cardiovascular disease

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24295849%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Salvatore Petta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24295849%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Fabio Macaluso

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24295849%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Salvatore Petta

1

1 reference

30 August 2017

Fabio Salvatore Macaluso

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

2 December 2013

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24295849%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24295849%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24295849%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

369-375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24295849%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

The interaction of metabolic factors with HCV infection: does it matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III].

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Association between hepatitis C virus core protein and carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Hepatitis B and C virus infection and the risk of atherosclerosis in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Evidence for association between hepatitis C virus seropositivity and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Association between chronic hepatitis C infection and coronary flow reserve in dialysis patients with failed renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

No association between hepatitis C virus seropositivity and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Lack of any association between persistent hepatitis B or C virus infection and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Associations of chronic hepatitis C with metabolic and cardiac outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Myocardial injury in patients with chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Does hepatitis C virus infection increase risk for stroke? A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Hepatitis C virus infection and increased risk of cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Hepatitis C virus infection and the risk of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Insulin resistance, metabolic stress, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Methods of accelerated atherosclerosis in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Determinants of increased cardiovascular disease in obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

The hepatitis C virus-associated dysmetabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Public health: The toxic truth about sugar

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

The role of vitamin D in cardiovascular disease: from present evidence to future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Genetics of coronary artery disease: genome-wide association studies and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

TNF-α polymorphisms and coronary artery disease: association study in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

PPARgamma promoter polymorphisms and acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Iron involvement in multiple signaling pathways of atherosclerosis: a revisited hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Hepatitis C virus RNA localization in human carotid plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Sofosbuvir for previously untreated chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102

Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306102